Equity Overview
Price & Market Data
Price: $0.028
Daily Change: $0.00 / 0.00%
Range: $0 - $0
Market Cap: $20,958,644
Volume: 0
Performance Metrics
1 Week: 1.82%
1 Month: 86.67%
3 Months: -20.00%
6 Months: -7.28%
1 Year: -20.00%
YTD: -6.67%
Details
Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States and Australia. Its products include FebriDx, a point-of-care diagnostic test for detecting and differentiating viral and bacterial respiratory infections; and ViraDx, a three-in-one point-of-care test for influenza A, influenza B, and COVID-19. It also offers disposable, Lumos Leelu, and hand-held readers. The company was incorporated in 2018 and is based in Carlsbad, California.